Global Industrial Biomanufacturing Market Report 2026-2036: Sustainability, Synthetic Biology, And Circular Economy Drive Growth

(MENAFN- GlobeNewsWire - Nasdaq) The newly released "Global Industrial Biomanufacturing Market 2026-2036" report offers in-depth analysis across various biomanufacturing segments, including detailed geographic, competitive, and technological insights, positioning this sector as a critical nexus for sustainability and economic growth.

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Global Industrial Biomanufacturing Market 2026-2036" report has been added to ResearchAndMarkets's offering.

The global industrial biomanufacturing market represents a transformative force in industrial production. This sector encompasses the production of pharmaceuticals, industrial chemicals, biofuels, biomaterials, and specialty products through biological processes, fundamentally reshaping how humanity approaches manufacturing. Biomanufacturing's significance extends far beyond economic metrics, positioning itself as a cornerstone of sustainable industrial development. Unlike traditional petrochemical manufacturing that relies on finite fossil fuel resources, biomanufacturing utilizes renewable biological feedstocks including agricultural residues, algae, and even carbon dioxide. This transition addresses critical resource scarcity challenges while reducing dependence on volatile petroleum markets.

The sector's contribution to the circular economy is particularly profound. Biomanufacturing processes excel at converting waste streams into valuable products, exemplifying circular economy principles. Agricultural waste becomes biofuels, food processing byproducts transform into specialty chemicals, and municipal solid waste generates bioplastics. This waste-to-value conversion reduces landfill burdens while creating economic value from previously discarded materials.

Environmental benefits are substantial and measurable. Biomanufacturing typically reduces greenhouse gas emissions by 30-80% compared to conventional processes, with some applications achieving carbon neutrality or even carbon negativity. The mild operating conditions of biological processes - typically 20-80C versus 200-800C for chemical processes - dramatically reduce energy consumption. Water usage often decreases through closed-loop systems and biological treatment processes that simultaneously purify and utilize water resources.

Biomanufactured drugs, including monoclonal antibodies, vaccines, and gene therapies, have revolutionized medical treatment while establishing robust regulatory frameworks that benefit other sectors. Industrial biotechnology applications are rapidly expanding, with bio-based chemicals, enzymes, and materials increasingly replacing petroleum-derived alternatives. Innovation drivers include advances in synthetic biology, which enable precise engineering of biological systems for specific applications. CRISPR gene editing, artificial intelligence, and automated bioprocessing are accelerating development cycles while reducing costs. These technological advances are making biomanufacturing economically competitive with traditional processes across an expanding range of products.

Regulatory support is strengthening globally, with governments implementing policies that favor bio-based products through tax incentives, carbon pricing, and procurement preferences. Challenges persist, including scale-up complexities, regulatory approval timelines, and competition from established petrochemical industries. However, the convergence of environmental necessity, technological capability, and economic opportunity positions biomanufacturing as an essential component of sustainable industrial development.

The circular economy integration is particularly evident in emerging biorefinery concepts that process multiple feedstocks into diverse product portfolios, maximizing resource utilization while minimizing waste generation. These integrated approaches represent the future of sustainable manufacturing, where biological processes serve as the foundation for truly circular industrial ecosystems.

The Global Industrial Biomanufacturing Market 2026-2036 report provides an exhaustive analysis of the rapidly expanding biomanufacturing industry. This comprehensive market intelligence study examines the transformative shift toward biological production systems across pharmaceuticals, industrial chemicals, biofuels, biomaterials, and specialty applications.

The biomanufacturing market represents a critical nexus of sustainability, innovation, and economic growth, addressing global challenges including climate change, resource scarcity, and industrial decarbonization. This sector leverages living systems and biological processes to manufacture products traditionally produced through petrochemical routes, offering superior environmental profiles and often enhanced performance characteristics.

The report analyzes eight primary market segments: biopharmaceuticals, industrial enzymes, biofuels, bioplastics, biochemicals, bio-agritech, specialty chemicals, and emerging applications. Geographic analysis covers North America, Europe, Asia-Pacific, Latin America, and Middle East/Africa markets with detailed country-level assessments. Competitive landscape analysis profiles over 1,050 companies across the value chain, from technology developers to commercial manufacturers.

The study identifies key strategic partnerships, mergers and acquisitions, and technology licensing agreements shaping market evolution. Innovation trends including cell-free systems, continuous manufacturing, and circular economy integration receive detailed examination.

Report Scope:

• Executive Summary and Market Overview
  • Global market sizing and growth projections 2026-2036
  • Technology trends and innovation drivers
  • Regulatory landscape and policy impacts
  • Competitive dynamics and market structure
• Production Technologies and Manufacturing Systems
  • Upstream processing: cell culture, fermentation advances
  • Synthetic biology tools: CRISPR, DNA synthesis, protein engineering
  • Downstream processing improvements and automation
  • Alternative feedstocks and sustainability frameworks
  • Scale-up strategies and commercial manufacturing
• Biopharmaceuticals Market
  • Monoclonal antibodies, recombinant proteins, vaccines
  • Cell and gene therapies, nucleic acid therapeutics
  • Generative biology and AI-driven drug discovery
  • Market growth drivers, regulatory frameworks
  • Company profiles of 131 leading organizations
• Industrial Enzymes and Biocatalysts Market
  • Detergent, food processing, textile applications
  • Bioenergy enzymes and carbon capture technologies
  • Plastics recycling and waste management applications
  • Technology readiness assessments and market forecasts
  • Profiles of 59 specialized enzyme companies
• Biofuels Market
  • Bioethanol, biodiesel, biogas production pathways
  • Advanced biofuels: renewable diesel, bio-aviation fuel
  • Feedstock analysis: first through fourth-generation
  • Regional market dynamics and policy frameworks
  • Analysis of 212 biofuel companies globally
• Bioplastics Market
  • PLA, PHAs, bio-based polyethylene markets
  • Cellulose-based and starch-based alternatives
  • Application markets and performance characteristics
  • Sustainability profiles and end-of-life management
  • Comprehensive profiles of 585 companies
• Biochemicals Market
  • Organic acids, amino acids, alcohol production
  • Bio-based monomers and polymer intermediates
  • Beauty and personal care applications
  • Market economics and competitive positioning
  • Analysis of 158 biochemical companies
• Bio-Agritech Market
  • Biopesticides, biofertilizers, biostimulants
  • Agricultural enzymes and crop enhancement
  • Regulatory frameworks and adoption patterns
  • Market growth projections by application
  • Profiles of 105 bio-agritech innovators

Companies Profiled Include:

• AbbVie
• Absci Corp
• Advanced Biochemical
• Aemetis
• AI Proteins
• Algal Bio
• Algenol
• Allozymes
• Alnylam Pharmaceuticals
• Alto Neuroscience
• Amgen
• AMSilk GmbH
• Amyris
• Anellotech
• Antheia
• Applied Bioplastics
• Aquafil
• Arzeda
• Arsenal Bioyards
• AstraZeneca
• Atomwise
• Avantium
• BASF
• Bayer CropScience
• BenevolentAI
• BioAge Labs
• Biocatalysts Ltd
• Biogen
• BioMADE
• Biomatter Designs
• BioNTech
• Biotalys
• BitBiome
• Bolt Threads
• Braskem
• Brevel
• Bristol Myers Squibb
• C16 Biosciences
• Carbios
• Cargill
• Cascade Biocatalysts
• Cemvita
• Citroniq Chemicals
• CJ Biomaterials
• Codexis
• Conagen
• Corteva Agriscience
• Cradle
• CSL Behring
• Danimer Scientific
• Deep Genomics
• Differential Bio
• DSM-Firmenich
• DuPont
• Ecovative Design
• Enduro Genetics
• Enzymaster
• Evogene
• Exscientia
• FabricNano
• Foray Bioscience
• Future Fields
• Generate Biomedicines
• Genesis Therapeutics
• GenesisM
• Genomatica
• Gevo
• Gilead Sciences
• Ginkgo Bioworks
• Global Bioenergies
• Green Earth Institute
• Healx
• Hydrosome Labs
• Iambic Therapeutics
• Inari
• Indigo Ag
• Infinited Fiber Company
• Insilico Medicine
• InSpek
• Insempra
• Insitro
• Isomorphic Laboratories
• Johnson & Johnson
• Kalion
• Kaneka Corporation
• Keel Labs
• Kraig Biocraft Laboratories
• LanzaTech
• Lenzing AG
• LG Chem
• Locus Agricultural Solutions
• Lygos
• Mango Materials
• Manus
• Marrone Bio Innovations
• METabolic EXplorer
• Moderna
• Modern Meadow
• MojiaBio
• Moolec Science
• MycoWorks
• Nanollose
• NatureWorks
• Neste
• Novartis
• Novomer
• Novozymes
• Paques Biomaterials
• Pfizer
• Pivot Bio
• Prolific Machines
• Provectus Algae
• Recursion Pharmaceuticals
• Regeneron
• Renmatix
• Roche
• Roquette
• Samsung Biologics
• Sanofi
• Solugen
• Spiber
• Syngenta
• Terramera
• TotalEnergies Corbion
• Tropic Biosciences
• Unilever
• Vertex Pharmaceuticals
• Virent
• Zymergen
• Zelixir
• and many more.....

The report includes these components:

• PDF report. Print edition also available.
• Comprehensive Excel spreadsheet of all data.
• Mid-year Update

Key Topics Covered:

1 EXECUTIVE SUMMARY
1.1 Definition and Scope of Industrial Biomanufacturing
1.2 Overview of Industrial Biomanufacturing Processes
1.3 Key Components of Industrial Biomanufacturing
1.4 Importance of Industrial Biomanufacturing in the Global Economy
1.5 Colours of Biotechnology
1.6 Markets
1.7 AI and Robotics in Biomanufacturing
1.8 Other Advanced and Emerging Technologies in Biomanufacturing

2 PRODUCTION
2.1 Microbial Fermentation
2.2 Mammalian Cell Culture
2.3 Plant Cell Culture
2.4 Insect Cell Culture
2.5 Transgenic Animals
2.6 Transgenic Plants
2.7 Technologies
2.8 Scale of Production
2.9 Mode of Operation
2.10 Host Organisms

3 BIOPHARMACEUTICALS
3.1 Overview
3.2 Technology/materials analysis
3.3 Market analysis
3.4 Company profiles (131 company profiles)

4 INDUSTRIAL ENZYMES (BIOCATALYSTS)
4.1 Overview
4.2 Technology/materials analysis
4.3 Market analysis
4.4 Company profiles (63 company profiles)

5 BIOFUELS
5.1 Overview
5.2 Technology/materials analysis
5.3 Market analysis
5.4 Company profiles (233 company profiles)

6 BIOPLASTICS
6.1 Overview
6.2 Technology/materials analysis
6.3 Market analysis
6.4 Company profiles (581 company profiles)

7 BIOCHEMICALS
7.1 Overview
7.2 Technology/materials analysis
7.3 Market analysis
7.4 Company profiles (138 company profiles)

8 BIO-AGRITECH
8.1 Overview
8.2 Technology/materials analysis
8.3 Market analysis
8.4 Company profiles (105 company profiles)

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN10092025004107003653ID1110041680